-
Meet Blue Serenity, Canada's First Natural Therapeutic Psilocybin Product For Approved Patients
Wednesday, August 10, 2022 - 11:26am | 464The Canadian-based company licensed by Health Canada for psychedelic and functional mushrooms production, Optimi Health Corp. (OTCQX: OPTHF), together with psilocybin patient and advocate Thomas Hartle, are launching Blue Serenity, Canada’s first natural therapeutic psilocybin product. Coming...
-
What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture
Monday, August 8, 2022 - 2:11pm | 588Optimi Health Corp. (OTCQX: OPTHF), the Canadian licensed psychedelic and functional mushrooms producer has signed a partnership agreement with psilocybin patient advocate Thomas Hartle to produce a novel homegrown, natural therapeutic psilocybin product for approved patients. Who Is Thomas...